Beta Bionics is targeting a valuation of up to $695 million in an upsized initial public offering, the insulin delivery device maker said on Tuesday.
Euronext has launched the 2025 edition of its IPOready programme, marking a decade of supporting Europe’s fastest-growing companies. Over 160 com ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback